New Jersey Pharmaceutical Regulatory Affairs
Exam Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF
1. Which federal agency has primary responsibility for approving most new
human prescription drugs in the United States?
A. DEA
B. FDA
C. CDC
D. FTC
Correct Answer: B. FDA
Rationale: The FDA evaluates the safety, effectiveness, labeling, and
manufacturing controls of human drugs before marketing authorization.
2. What is the primary purpose of a New Drug Application (NDA)?
A. To register a pharmacy
B. To obtain FDA approval to market a new drug
C. To schedule a controlled substance
D. To report an adverse event
Correct Answer: B. To obtain FDA approval to market a new drug
Rationale: An NDA is the formal application through which a sponsor asks FDA to
approve a new pharmaceutical product for marketing in the United States.
,3. Which application is generally used to seek approval for a generic drug?
A. IND
B. BLA
C. ANDA
D. DMF
Correct Answer: C. ANDA
Rationale: An Abbreviated New Drug Application is the principal FDA pathway for
approving qualifying generic drugs.
4. What is the primary function of an Investigational New Drug (IND)
application?
A. To obtain permission to conduct certain clinical investigations using an
investigational drug
B. To renew a pharmacy license
C. To establish a drug's NDC number
D. To register a wholesaler
Correct Answer: A. To obtain permission to conduct certain clinical
investigations using an investigational drug
Rationale: An IND supports the legal initiation and continuation of clinical
investigation of an investigational drug under applicable FDA requirements.
5. Which FDA application is primarily associated with biological products?
A. BLA
B. ANDA
C. NDA
D. DMF
Correct Answer: A. BLA
,Rationale: A Biologics License Application is used for licensing applicable biological
products regulated by FDA.
6. What does CGMP stand for?
A. Controlled Government Manufacturing Procedure
B. Current Good Manufacturing Practice
C. Certified General Manufacturing Program
D. Current Government Medication Policy
Correct Answer: B. Current Good Manufacturing Practice
Rationale: CGMP establishes regulatory requirements for manufacturing,
processing, packing, holding, testing, and quality control of drugs. FDA's finished-
pharmaceutical CGMP requirements are principally found in 21 CFR Parts 210 and
211.
7. Which regulation primarily addresses CGMP requirements for finished
pharmaceuticals?
A. 21 CFR Part 11
B. 21 CFR Part 211
C. 21 CFR Part 314 only
D. 21 CFR Part 803
Correct Answer: B. 21 CFR Part 211
Rationale: 21 CFR Part 211 contains CGMP requirements specifically for finished
pharmaceuticals.
8. What is the main regulatory purpose of pharmaceutical product labeling?
A. To promote a product regardless of indication
B. To provide accurate information for safe and effective use
, C. To replace clinical trials
D. To eliminate postmarketing surveillance
Correct Answer: B. To provide accurate information for safe and effective use
Rationale: FDA-approved labeling communicates essential information needed for
safe and effective use of the product.
9. A pharmaceutical company discovers that approved labeling contains a
significant safety error. What should regulatory affairs primarily coordinate?
A. Ignoring the issue until the next annual review
B. Appropriate regulatory assessment and corrective labeling action
C. Immediate destruction of all records
D. Changing the active ingredient
Correct Answer: B. Appropriate regulatory assessment and corrective labeling
action
Rationale: Significant labeling errors can create patient-safety and regulatory risks
and require documented evaluation and, where appropriate, regulatory
communication or submission.
10. Which FDA publication is commonly used to evaluate approved drug
products and therapeutic equivalence?
A. Orange Book
B. Purple Book exclusively
C. Red Book
D. Green Book
Correct Answer: A. Orange Book
Rationale: FDA's Orange Book identifies approved drug products and provides
therapeutic-equivalence evaluations and patent/exclusivity information.
Exam Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF
1. Which federal agency has primary responsibility for approving most new
human prescription drugs in the United States?
A. DEA
B. FDA
C. CDC
D. FTC
Correct Answer: B. FDA
Rationale: The FDA evaluates the safety, effectiveness, labeling, and
manufacturing controls of human drugs before marketing authorization.
2. What is the primary purpose of a New Drug Application (NDA)?
A. To register a pharmacy
B. To obtain FDA approval to market a new drug
C. To schedule a controlled substance
D. To report an adverse event
Correct Answer: B. To obtain FDA approval to market a new drug
Rationale: An NDA is the formal application through which a sponsor asks FDA to
approve a new pharmaceutical product for marketing in the United States.
,3. Which application is generally used to seek approval for a generic drug?
A. IND
B. BLA
C. ANDA
D. DMF
Correct Answer: C. ANDA
Rationale: An Abbreviated New Drug Application is the principal FDA pathway for
approving qualifying generic drugs.
4. What is the primary function of an Investigational New Drug (IND)
application?
A. To obtain permission to conduct certain clinical investigations using an
investigational drug
B. To renew a pharmacy license
C. To establish a drug's NDC number
D. To register a wholesaler
Correct Answer: A. To obtain permission to conduct certain clinical
investigations using an investigational drug
Rationale: An IND supports the legal initiation and continuation of clinical
investigation of an investigational drug under applicable FDA requirements.
5. Which FDA application is primarily associated with biological products?
A. BLA
B. ANDA
C. NDA
D. DMF
Correct Answer: A. BLA
,Rationale: A Biologics License Application is used for licensing applicable biological
products regulated by FDA.
6. What does CGMP stand for?
A. Controlled Government Manufacturing Procedure
B. Current Good Manufacturing Practice
C. Certified General Manufacturing Program
D. Current Government Medication Policy
Correct Answer: B. Current Good Manufacturing Practice
Rationale: CGMP establishes regulatory requirements for manufacturing,
processing, packing, holding, testing, and quality control of drugs. FDA's finished-
pharmaceutical CGMP requirements are principally found in 21 CFR Parts 210 and
211.
7. Which regulation primarily addresses CGMP requirements for finished
pharmaceuticals?
A. 21 CFR Part 11
B. 21 CFR Part 211
C. 21 CFR Part 314 only
D. 21 CFR Part 803
Correct Answer: B. 21 CFR Part 211
Rationale: 21 CFR Part 211 contains CGMP requirements specifically for finished
pharmaceuticals.
8. What is the main regulatory purpose of pharmaceutical product labeling?
A. To promote a product regardless of indication
B. To provide accurate information for safe and effective use
, C. To replace clinical trials
D. To eliminate postmarketing surveillance
Correct Answer: B. To provide accurate information for safe and effective use
Rationale: FDA-approved labeling communicates essential information needed for
safe and effective use of the product.
9. A pharmaceutical company discovers that approved labeling contains a
significant safety error. What should regulatory affairs primarily coordinate?
A. Ignoring the issue until the next annual review
B. Appropriate regulatory assessment and corrective labeling action
C. Immediate destruction of all records
D. Changing the active ingredient
Correct Answer: B. Appropriate regulatory assessment and corrective labeling
action
Rationale: Significant labeling errors can create patient-safety and regulatory risks
and require documented evaluation and, where appropriate, regulatory
communication or submission.
10. Which FDA publication is commonly used to evaluate approved drug
products and therapeutic equivalence?
A. Orange Book
B. Purple Book exclusively
C. Red Book
D. Green Book
Correct Answer: A. Orange Book
Rationale: FDA's Orange Book identifies approved drug products and provides
therapeutic-equivalence evaluations and patent/exclusivity information.
